New imaging probe to improve bladder cancer diagnosis
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new optical probe that gives doctors a clearer view of bladder tumors during cystoscopy. It may help make diagnosis and treatment more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least one suspected bladder tumor seen during a cystoscopy.
- Your bladder can be reached with a cystoscope.
- You are healthy enough to undergo a TURBT procedure.
- You are able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan (mpMRI) to figure out how far suspected muscle-invasive bladder cancer has spread, using a new local staging approach. If the results are accurate, it may help doctors plan the most appropriate curative treatment sooner.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This study uses a special ultrasound technique to take detailed pictures of the tiny blood vessels around bladder cancer. The goal is to help doctors better understand the cancer before surgery to remove the bladder.
This trial tests if using blue light during surgery helps remove all cancer in people with high-risk non-muscle invasive bladder cancer. It may lower the chance of the cancer coming back.
This trial is testing whether artificial intelligence (AI) can help surgeons perform a more precise removal of bladder tumors during a procedure called TURBT. It is for people with early-stage bladder cancer that hasn't spread into the muscle layer.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.